Herantis Pharma Oyj: Manager's Transactions - Pekka Simula
Herantis Pharma Plc
Company release 21 December 2018 at 9:00 am
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Pekka Simula
Position: Chief Executive Officer
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20181220192048_3
____________________________________________
Transaction date: 2018-12-20
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 166 Unit price: 4.98 EUR
(2): Volume: 500 Unit price: 5 EUR
(3): Volume: 131 Unit price: 5 EUR
(4): Volume: 150 Unit price: 5.2 EUR
(5): Volume: 53 Unit price: 5.7 EUR
Aggregated transactions
(5): Volume: 1,000 Volume weighted average price: 5.06378 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com